Insulin clearance in obesity

被引:113
作者
Mora, MEV [1 ]
Scarfone, A [1 ]
Calvani, M [1 ]
Greco, AV [1 ]
Mingrone, G [1 ]
机构
[1] Catholic Univ, Inst Internal Med, I-00168 Rome, Italy
关键词
insulin clearance; obesity; insulin resistance; diabetes mellitus; insulin degrading enzyme; liver clearance; kidney clearance;
D O I
10.1080/07315724.2003.10719326
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Insulin uptake and degradation is a complex and not yet completely understood process involving not only insulin sensitive tissues. The most important degradative system is insulin degrading enzyme which is a highly conserved metalloendopeptidase requiring Zn++ for its proteolytic action, although protein disulfide isomerase and cathepsin D are also involved in insulin metabolism. The liver and the kidney are the principal sites for insulin clearance. In obese subjects with hyperinsulinemia and high levels of free fatty acids, insulin hepatic clearance is impaired, while the glomerular filtration rate, renal plasma flow and albumin excretion are increased, suggesting a state of renal vasodilatation leading to an abnormally transmitted arterial pressure to the glomerular capillaries through a dilated afferent arteriole. Insulin can be cleared also by muscle, adipocytes, gastrointestinal cells, fibroblasts, monocytes and lymphocytes which contain insulin receptors and internalization and regulation mechanism for insulin metabolism.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 53 条
[1]   DEGRADATION OF THE CLEAVED LEADER PEPTIDE OF THIOLASE BY A PEROXISOMAL PROTEINASE [J].
AUTHIER, F ;
BERGERON, JJM ;
OU, WJ ;
RACHUBINSKI, RA ;
POSNER, BI ;
WALTON, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3859-3863
[2]  
Baldeweg SE, 2000, EUR J CLIN INVEST, V30, P45
[3]   AN UNUSUAL ACTIVE-SITE IDENTIFIED IN A FAMILY OF ZINC METALLOENDOPEPTIDASES [J].
BECKER, AB ;
ROTH, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3835-3839
[4]   INSULIN DEGRADATION IN-VITRO AND IN-VIVO - A COMPARATIVE-STUDY IN MEN - EVIDENCE THAT IMMUNOPRECIPITABLE, PARTIALLY REBINDABLE DEGRADATION PRODUCTS ARE RELEASED FROM CELLS AND CIRCULATE IN BLOOD [J].
BENZI, L ;
CECCHETTI, P ;
CICCARONE, A ;
PILO, A ;
DICIANNI, G ;
NAVALESI, R .
DIABETES, 1994, 43 (02) :297-304
[5]   MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE [J].
BODEN, G ;
CHEN, XH ;
RUIZ, J ;
WHITE, JV ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2438-2446
[6]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[7]   ATP inhibits insulin-degrading enzyme activity [J].
Camberos, MC ;
Pérez, AA ;
Udrisar, DP ;
Wanderley, MI ;
Cresto, JC .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (04) :334-341
[8]   RAT INSULIN TURNOVER IN-VIVO [J].
CANAS, X ;
FERNANDEZLOPEZ, JA ;
ARDEVOL, A ;
ADAN, C ;
ESTEVE, M ;
RAFECAS, I ;
REMESAR, X ;
ALEMANY, M .
ENDOCRINOLOGY, 1995, 136 (09) :3871-3876
[9]   HOW TO MEASURE INSULIN-CLEARANCE [J].
CASTILLO, MJ ;
SCHEEN, AJ ;
LETIEXHE, MR ;
LEFEBVRE, PJ .
DIABETES-METABOLISM REVIEWS, 1994, 10 (02) :119-150
[10]   Glomerular hemodynamics in severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Korzets, A ;
Ramadan, E ;
Hirsch, J ;
Gafter, U .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) :F817-F822